All Schrödinger offices worldwide will be closed for the week of August 17-21 as part of a company-wide initiative to rest and recharge. Please expect limited responses during this time. Scientific and Technical Support team members will be available to answer emergency support issues only.

NOV 7, 2018

An Overview of Covalent Docking and FEP, using the Example of Cathepsin Binders Inhibitors

Thomas Steinbrecher
Principal Scientist

Key highlights:

  • Covalent Ligands in Drug Design: Things Modelers should be thinking about
  • Setting up a covalent docking job
  • Using the FEP Covalent Docking panel
  • Results and analysis